News and Media

04 Nov

We need better treatments for childhood cancer, with less side effects

The Australian government today announced A$20 million for research to find targeted treatments for childhood cancer. In announcing the grant, for the Zero Childhood Cancer Program led by the Children’s Cancer Institute and Sydney Children’s Hospital, Health Minister Sussan Ley said, “Cancer has just passed cardiovascular disease as the leading cause of death in Australia

Read More
03 Nov

Professor John Zalcberg OAM appointed as inaugural Tony Charlton Chair of Oncology

  The Alfred Hospital announced Prof John Zalcberg OAM as the inaugural Tony Charlton Chair of Oncology  on 3rd November. A joint appointment between Monash University and the Alfred, this leadership position will steer the Alfred’s oncology program into the future, cultivating innovative new treatments and transferring research findings into clinical practice. Prof Zalcberg currently

Read More
03 Nov

Fasting may improve cancer treatment, but needs further exploration

The gold standard treatment for cancer in the last few decades has been a combination of surgery – to remove tumours – and chemotherapy and radiotherapy – to kill cancer cells. With the progress of personalised medicine, where identifying specific mutations in the tumour guides treatment selection, there has been increasing success in survival rates.

Read More
01 Nov

Dr Sam Greenall named inaugural Ethan Davies Fellow

Dr Sam Greenall from Hudson Institute’s Centre for Cancer Research has been awarded the inaugural Ethan Davies Fellowship, to develop “dish-grown” tumour cultures that can be used to screen new drug treatments for a rare type of brain cancer. Dr Greenall was announced as the inaugural recipient of the Fellowship at an official launch hosted

Read More
28 Oct

MPCCC 2015 – 2016 Annual Report

The Monash Partners Comprehensive Cancer Consortium’s (MPCCC) Annual Report 2015-2016 is now available for download. (please note: this file is 12MB) Featuring selected highlights of biomedical, translational and clinical cancer research from Monash Comprehensive Cancer Consortium’s (MCCC) partner organisations, alongside the service improvement activities undertaken by the Southern Melbourne Integrated Cancer Service (SMICS) team in

Read More
28 Oct

MPCCC 2016 Cancer Forum

The Monash Partners Comprehensive Cancer Consortium (MPCCC) was joined by over 170 guests at its 2016 Cancer Forum, which was hosted at the Metropolitan Golf Club on 18 October. Chaired by Prof John Zalcberg, Head of Cancer Research at Monash University’s Department of Epidemiology and Preventive Medicine, the 2016 Cancer Forum featured presentations from MPCCC

Read More
28 Oct

Prostate Cancer Summit Report October 2016

The Prostate Cancer Summit was held in Melbourne on 25th May this year, gathering 70 multidisciplinary delegates from across Victoria to identify practical and achievable actions that could have a positive impact on patient outcomes. The summit was a call to all with a stake in achieving better outcomes for men with prostate cancer for

Read More
28 Oct

Oesophagogastric Cancer Summit Report September 2016

Improving outcomes for people with Oesophagogastric (OG) cancers is particularly challenging. Chances for early detection are slim and many present at a late stage of disease. Members of OG cancer multidisciplinary teams across Victoria gathered on the 26th of August this year to review variations in care and identify opportunities to improve the outcomes and

Read More
28 Oct

Melanoma Fears

A psychological support service has been found to help alleviate common fears shared by people who have had melanomas that the potentially deadly skin cancer will return. A trial of 164 patients showed that the number of people who had those fears halved when given three telephone-based support sessions with psychologists. Those that took part

Read More
24 Oct

Molecular Analysis of Paediatric Brain Cancer Could Become ‘Gold Standard’ For Tailored Treatment

Researchers at Hudson Institute of Medical Research are working to establish and pilot an Australian-first service for analysing the most common type of paediatric solid brain cancer tumour, medulloblastoma, to enable more effective treatment for these paediatric brain cancer patients. Involving a collaborative team of researchers and clinicians from Hudson Institute, Monash Health and Monash

Read More
Page 5 of 10« First...34567...10...Last »